Disorders of gut–brain interaction in Aotearoa New Zealand: a long-standing evidence gap with unmeasured health and economic consequences

aim: The aim of this viewpoint was to summarise evidence regarding prevalence and economic burden of disorders of gut–brain interaction (DGBI), e.g., irritable bowel syndrome (IBS), in Aotearoa New Zealand and estimate their likely scale using comparable-country data. methods: We conducted a scoping review of Ovid Embase and PubMed (searched on 10 December 2025) for studies reporting adult DGBI prevalence or economic burden in New Zealand, the United Kingdom (UK) and Australia. New Zealand data were included regardless of diagnostic criteria; UK and Australian data were restricted to Rome IV studies. results: Only four New Zealand prevalence studies were identified, the most recent published in 2002; no study has reported DGBI prevalence in Māori or Pacific people. Two small, industry-linked New Zealand cost studies were identified. UK and Australian Rome IV data indicate adult DGBI prevalence of approximately 37%, with significant healthcare expenditure and productivity loss. Extrapolating UK mean direct costs per IBS patient to one-third of New Zealand’s adults, direct healthcare utilisation costs are approximately NZ$1.6 billion annually, with total costs approaching 1% of gross domestic product. conclusion: New Zealand lacks contemporary prevalence data, equity-specific data for Māori and credible cost-of-illness estimates for DGBI. Extrapolation from comparable countries suggests the true burden is large and current research and clinical investment are extraordinarily mismatched to it.

Authors

Publication Details

Journal
New Zealand Medical Journal
Published
2026-11-20
DOI
https://doi.org/10.26635/6965.7608
Primary Topic
Gastrointestinal motility and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Disorders of gut–brain interaction in Aotearoa New Zealand: a long-standing evidence gap with unmeasured health and economic consequences

Jody Miller, Simone Bayer, Nathan Berg
1 links
New Zealand Medical Journal
Gastrointestinal motility and disorders
article

Disorders of gut–brain interaction in Aotearoa New Zealand: a long-standing evidence gap with unmeasured health and economic consequences

Jody Miller, Simone Bayer, Nathan Berg
article en

Abstract

aim: The aim of this viewpoint was to summarise evidence regarding prevalence and economic burden of disorders of gut–brain interaction (DGBI), e.g., irritable bowel syndrome (IBS), in Aotearoa New Zealand and estimate their likely scale using comparable-country data. methods: We conducted a scoping review of Ovid Embase and PubMed (searched on 10 December 2025) for studies reporting adult DGBI prevalence or economic burden in New Zealand, the United Kingdom (UK) and Australia. New Zealand data were included regardless of diagnostic criteria; UK and Australian data were restricted to Rome IV studies. results: Only four New Zealand prevalence studies were identified, the most recent published in 2002; no study has reported DGBI prevalence in Māori or Pacific people. Two small, industry-linked New Zealand cost studies were identified. UK and Australian Rome IV data indicate adult DGBI prevalence of approximately 37%, with significant healthcare expenditure and productivity loss. Extrapolating UK mean direct costs per IBS patient to one-third of New Zealand’s adults, direct healthcare utilisation costs are approximately NZ$1.6 billion annually, with total costs approaching 1% of gross domestic product. conclusion: New Zealand lacks contemporary prevalence data, equity-specific data for Māori and credible cost-of-illness estimates for DGBI. Extrapolation from comparable countries suggests the true burden is large and current research and clinical investment are extraordinarily mismatched to it.

New Zealand Medical JournalVol. 139(1646)
Good health and well-being
Gastrointestinal motility and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon